Rhabdomyolysis was not reported in clinical trials with Sitagliptin alone. However, several reports in the literature on rhabdomyolysis resulted from the interaction between statins and Sitagliptin. In patients with type 2 diabetes and hyperlipidemia, it is expected to co-prescribe statins and Sitagliptin. Herein, we report the case of a 64-year-old woman with rhabdomyolysis should be caused by a drug-drug interaction between Rosuvastatin and Sitagliptin. The patient denied any history of weakness or myalgia during past medical assessments.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367606 | PMC |
| http://dx.doi.org/10.1177/11795476241274162 | DOI Listing |
Publication Analysis
Top Keywords
statins sitagliptin
8
sitagliptin
5
rosuvastatin-induced rhabdomyolysis
4
rhabdomyolysis result
4
result drug
4
drug interaction
4
interaction sitagliptin
4
sitagliptin case
4
case report
4
report rhabdomyolysis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!